| Patents for A61P 27 - Drugs for disorders of the senses (53,017) |
|---|
| 06/26/2013 | CN103169813A Compound traditional Chinese medicine preparation for treating viral keratitis |
| 06/26/2013 | CN103169798A Chinese medicinal composition for treating meniere disease and preparation method thereof |
| 06/26/2013 | CN103169760A Medicinal composition for treating chronic conjunctivitis |
| 06/26/2013 | CN103169759A Chinese medicinal composition for treating chronic conjunctivitis and preparation method thereof |
| 06/26/2013 | CN103169720A Application of anthracene nucleus antibiotic and its pharmaceutical salt for treating retinal vein occlusion |
| 06/26/2013 | CN103169719A Application of anthracene nucleus antibiotic and its pharmaceutical salt for treating diabetic eye diseases |
| 06/26/2013 | CN103169718A Application of anthracene nucleus antibiotic and its pharmaceutical salt for treating neovascular glaucoma |
| 06/26/2013 | CN103169717A Application of anthracene nucleus antibiotic and its pharmaceutical salt for treating ocular inflammation |
| 06/26/2013 | CN103169714A Methods and products for treatment of diseases |
| 06/26/2013 | CN103169708A Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds |
| 06/26/2013 | CN103169682A Polysaccharide sulfate tablet and preparation method of polysaccharide sulfate tablet |
| 06/26/2013 | CN102351934B Steroidal alkaloid compounds and pharmaceutical composition thereof, as well as preparation methods and applications of steroidal alkaloid compounds and pharmaceutical composition of compounds |
| 06/25/2013 | US8470784 Methods and compositions for preventing or treating ophthalmic conditions |
| 06/25/2013 | US8469934 Pulsatile peri-corneal drug delivery device |
| 06/25/2013 | CA2591912C Pyrimidinylisoxazole derivatives |
| 06/25/2013 | CA2521885C Once daily formulations of tetracyclines |
| 06/25/2013 | CA2444894C Sustained release drug delivery system containing codrugs |
| 06/20/2013 | WO2013090227A1 Benzisothiazol-3(1h)-one-5-sulfonyl derivatives as chemokine receptor modulators |
| 06/20/2013 | WO2013089835A1 Composition and method for treating nucleic acid-related eye disease |
| 06/20/2013 | WO2013089307A1 Composition for inhibiting after-cataract and method for preparing same |
| 06/20/2013 | WO2013087090A1 Treatment of tinnitus through modulation of chloride co-transporter nkcc1 in the auditory system |
| 06/20/2013 | WO2013063383A3 Vectors encoding rod-derived cone viability factor |
| 06/20/2013 | US20130158502 Method of inhibiting angiogenesis or invasion or formation of metastases |
| 06/20/2013 | US20130157965 Prevention and Treatment of Oxidative Stress Disorders by Glutathione and Phase II Detoxification Enzymes |
| 06/20/2013 | US20130156840 Implantable intraocular drug delivery apparatus, system and method |
| 06/20/2013 | US20130156696 Human antibodies against pseudomonas aeruginosa lps derived from transgenic xenomouse |
| 06/20/2013 | CA2853204A1 Methods and uses of anp (atrial natriuretic peptide), bnp (brain natriuretic peptide) and cnp (c-type natriuretic peptide)-related peptides and derivatives thereof for treatment of retinal disorders and diseases |
| 06/20/2013 | CA2849085A1 Treatment of tinnitus through modulation of chloride co-transporter nkcc1 in the auditory system |
| 06/19/2013 | EP2603588A1 Injectable pharmaceutical composition for preventing, stabilising and/or inhibiting pathological neovascularization-related conditions |
| 06/19/2013 | EP2603238A1 Methods and pharmaceutical compositions for the treatment of an ocular disease in a subject |
| 06/19/2013 | CN103168028A Cyclic amide derivative |
| 06/19/2013 | CN103167875A Ep2 or ep4 agonists for treating corneal haze |
| 06/19/2013 | CN103167873A Dosing regimes for the treatment of ocular vascular disease |
| 06/19/2013 | CN103160415A Tortoise shell cassia tora wine |
| 06/19/2013 | CN103159851A Micromolecule polypeptide preventing and restraining inflammation and application thereof |
| 06/19/2013 | CN103159788A Condensed imidazole formamide serving as transient receptor potential vanillin 3 (TRPV3) modifier |
| 06/19/2013 | CN103159726A Chromene ketone derivative used as transient receptor potential vanillin3 (TRPV3) antagonist |
| 06/19/2013 | CN103159667A 6-guanidyl-2H-isoindole compound as well as preparation method and application thereof |
| 06/19/2013 | CN103157097A Medicinal liquid for improving eye fatigue |
| 06/19/2013 | CN103156980A Chinese medicinal composition for treating cataract |
| 06/19/2013 | CN103156883A Medicine for treating otitis media |
| 06/19/2013 | CN103156867A Medical composition for preventing or treating amyloid beta peptide related diseases or conditions |
| 06/19/2013 | CN103156862A Compound voriconazole eardrops and preparation method thereof |
| 06/19/2013 | CN103156861A Application of oleanolic acid derivative and pharmaceutically acceptable salts thereof in diabetic eye disease treatment |
| 06/19/2013 | CN102199587B Functional mutant of human plasminogen, its preparation method and application |
| 06/19/2013 | CN102178956B Preparation, medical application and composition of 20S-protopanaxadiol beta-cyclodextrin inclusion compound |
| 06/19/2013 | CN102070712B VEGF-A (vascular endothelial growth factor-A) protein and use thereof |
| 06/19/2013 | CN101486701B Analogue compound, and analogue and medical use thereof |
| 06/19/2013 | CN101486700B 8-acetyl chromanone compound, and analogue and medical use thereof |
| 06/18/2013 | US8464711 Methods for treating headaches |
| 06/18/2013 | CA2438273C Tryptophanyl-trna synthetase derived polypeptides useful for the regulation of angiogenesis |
| 06/18/2013 | CA2422002C Vaccine |
| 06/13/2013 | WO2013085017A1 Pyridone derivative and medicine containing same |
| 06/13/2013 | WO2013085016A1 Pyridone derivative and medicine containing same |
| 06/13/2013 | WO2013084194A1 Topical pharmaceutical compositions of anti-microbial agents and anti-inflammatory agents |
| 06/13/2013 | WO2013083994A1 Hydantoin derivatives useful as kv3 inhibitors |
| 06/13/2013 | WO2013083569A1 Nasal formulation |
| 06/13/2013 | WO2013083552A1 Inhibition of cis-platin induced ototoxicity |
| 06/13/2013 | US20130150349 2,4-pyrimidinediamine compounds and their uses |
| 06/13/2013 | US20130150287 RECOMBINANT PROTEIN FOR INTRACELLULAR DELIVERY OF siRNA AND COMPOSITION COMPRISING THE SAME |
| 06/13/2013 | CA2858164A1 Pyridone derivative and medicine containing same |
| 06/13/2013 | CA2856654A1 Hydantoin derivatives useful as kv3 inhibitors |
| 06/13/2013 | CA2856043A1 Nasal formulation |
| 06/12/2013 | EP2601949A2 Pharmaceutical compositions |
| 06/12/2013 | EP2601945A1 Inhibition of cis-platin induced ototoxicity |
| 06/12/2013 | EP2600865A1 Compound useful for the treatment of nonsense-mutation-mediated diseases and pharmaceutical composition comprising said compound |
| 06/12/2013 | EP2600832A1 Combination of compounds for treating or preventing skin diseases |
| 06/12/2013 | CN1943577B Use of (2-imidazolin-2-ylamino) quinoxalines in treating ocular neural injury |
| 06/12/2013 | CN1942588B Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof |
| 06/12/2013 | CN1852971B Oligodendrocytes derived from human embryonic stem cells for remyelination and treatment of spinal cord injury |
| 06/12/2013 | CN1529753B Disease-associated protein |
| 06/12/2013 | CN103146554A Red date liquorice liquor |
| 06/12/2013 | CN103145851A Recombinant protein PACAP38-NtA, and coding gene and application thereof |
| 06/12/2013 | CN103145738A Imidazo [2,1-b] thiayole derivatives as SIRTUIN modulating compounds |
| 06/12/2013 | CN103145712A Substituted 8-[6-amino-3-pyridyl]xanthenes |
| 06/12/2013 | CN103143022A Ophthalmologic irrigation solutions and method |
| 06/12/2013 | CN103142968A Medicine for treating dry eye syndromes |
| 06/12/2013 | CN103142863A Chinese medicinal preparation for preventing and treating juvenile myopia and application thereof |
| 06/12/2013 | CN103142830A Nano high-selenium eyesight-improving snake gall liquor |
| 06/12/2013 | CN103142730A Hordeolum treating granules |
| 06/12/2013 | CN103142701A Ear dropping oil agent for mixed infection of pet ear canal and preparation method thereof |
| 06/12/2013 | CN103142601A Application of PCI (Percutaneous Coronary Intervention)-32765 for preparing anti-angiogenic medicines |
| 06/12/2013 | CN103142570A Use of low-dose Ladostigil for neuroprotection |
| 06/12/2013 | CN103142556A Polysaccharide sulfate sustained-release capsule and preparation method thereof |
| 06/12/2013 | CN103142539A Alginic sodium diester controlled-release tablet and preparation method thereof |
| 06/12/2013 | CN103142535A Alginic sodium diester enteric tablet and preparation method thereof |
| 06/12/2013 | CN103142468A Tacrolimus eye ointment for cornea transplantation and preparation method thereof |
| 06/12/2013 | CN103142463A Eye medicament composition as well as preparation method and application thereof |
| 06/12/2013 | CN103142462A Brinzolamide eye preparations, and preparation method and use thereof |
| 06/12/2013 | CN102378814B Monoclonal antibody capable of binding to specific discontinuous epitope occurring in ad1 region of human cytomegalovirus gb glycoprotein, and antigen-binding fragment thereof |
| 06/12/2013 | CN102309632B Application of pharmaceutical composition in preparation of pharmaceuticals for treating complications of diabetes |
| 06/12/2013 | CN102178784B Combination therapy used for treating visual disturbances and damages and relieving asthenopia |
| 06/12/2013 | CN102093353B 7-substituted aza-indazoles, compositions containing same, production method and use thereof |
| 06/12/2013 | CN101952261B Substituted cyclopentanes having prostaglanding activity |
| 06/12/2013 | CN101932575B Piperidine derivative |
| 06/12/2013 | CN101795692B Therapeutic substituted cyclopentanes for reducing intraocular pressure |
| 06/12/2013 | CN101684106B Thiazole onium salt compound and application for treating diseases relative to protein aging thereof |
| 06/12/2013 | CN101522631B Derivatives of 4-(2-amino-1-hydroxyethyl)phenol as agonists of the ss2 adrenergic receptor |
| 06/12/2013 | CN101229220B Compound for preventing and curing pseudomyopia and preparing method thereof |
| 06/11/2013 | US8460701 Synergistic antimicrobial preparations containing chlorite and hydrogen peroxide |